Positive inotropic therapy: Dead end or new horizon?

Journal of Cardiac Failure

Volumn 2, Issue SUPPL. 1, 1996, Pages

  Remme, Willem J ^a  

^a Sticares Cardiovascular Research Foundation   (Netherlands)

Author keywords

Calcium sensitizers; Digitalis; Heart failure; Mortality; Phosphodiesterase inhibitors; Positive inotropes; Treatment

Indexed keywords

CARDIOTONIC AGENT;

CONGESTIVE HEART FAILURE; HUMAN; REVIEW;

CARDIOTONIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0030344739     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(96)80087-X     Document Type: Article

References (18)

1. Massie B, Bourassa M, DiBianco R, Hess M, Konstam M, Likoff M, Packer M (for the Amrinone Multicentre study group): Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation 1985;71:963-971
2. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-683
3. Choraria SK, Taylor D, Pilcher J: Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure. Circulation 1987;76:1307-1311
4. Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benetti J, Murali S, Herrmann HC, Sandberg JA, (for the Enoximone Multicenter Trial Group): Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Circulation 1990;82:774-780
5. Narahara KA and the Western Enoximone Study Group: Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. Am Heart J 1991;121:1471-1479
6. The Xamoterol in Severe Heart Failure Study Group: Xamoterol in severe heart failure. Lancet 1990;336:1-6
7. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldia SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallia G, Sollano JA, Shannon J, Tandon PK, DeMets DL, (for the PROMISE Study Research Group): Effect of oral milrinone on mortality in severe chronic heart failure. N Eng J Med 1991;325:1468-1475
8. Holmes JR, Kubo SH, Cody RJ, Kligfield P: Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias. Am Heart J 1985;110:800-806
9. Anderson JL, Askins JC, Gilbert EM, Menlove RL, Lutz JR: Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986;111:466-474
10. Weber KT, Andrews V, Janicki JS, Likoff M, Reichek N: Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation 1982;66:1262-1267
11. Colucci WS, Alexander WR, Williams GH, Rude RE, Holman BL, Konstam MA, Wynne J, Mudge GH Jr, Braunwald E: Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med 1981;305:185-190
12. Mettauer B, Rouleau J-L, Burgess JH: Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure. Am Heart J 1985;109:840-847
13. Petein M, Levine TB, Cohn JN: Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Circulation 1986;73:III-230-236
14. Remme WJ: Vasodilator therapy without converting enzyme inhibition in congestive heart failure: usefulness and limitations. Cardiovasc Drugs Ther 1989;3:375-396
15. DiBianco R: Clinical results with oral milrinone in heart failure. Eur Heart J 1989;10(suppl C):44-52
16. Lejemtel TH, Gumbardo D, Chadwick B, Rutman HI, Sonnenblick EH: Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance. Circulation 1986;73(suppl III):III-213-III-218
17. Maskin CS, Weber KT, Janicki JS: Long-term oral enoximone therapy in chronic cardiac failure. Am J Cardiol 1987;60:63C-67C
18. Nemanich JW, Shurman AJ, Rossen JD, Kremser C, Davis F, Rajfer SI: Effects of long-term therapy with oral piroximone on resting hemodynamics, peak aerobic capacity and the anaerobic threshold in patients with heart failure. J Cardiovasc Pharmacol 1987;10:580-588